ArticleMolecular cancer therapeutics2020

A Precision Medicine Drug Discovery Pipeline Identifies Combined CDK2 and 9 Inhibition as a Novel Therapeutic Strategy in Colorectal Cancer.

Jason A Somarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.